baber/WOPTO huggingface dataset:
Patent MX-PA04002325-A (MX)
Title: Strain-relief device for a plug-in connection in communications and data systems.
Inventor: FERENC NAD
IPC: H01R13/658
Filed: 2002-08-12
Abstract: The invention relates to a strain-relief device (1) for a plug-in connector in communications and data systems. Said device comprises a base part (10) for receiving at least one part of the plug-in connector and a cable (51) that is to be connected to the plug-in connector. The base part (10) is configured with first detent means and a locking element (30), said locking element (30) being configured with second detent means, which form a detent connection with the first detent means of the base part (10). The locking element (30) is configured as a spring comprising two limbs (31), which can be displaced along a guide (20) on the base part (10). The base part (10) is configured with at least one support point (21) for the locking element (30) and the locking element (30) is designed in such a way that a counteracting force produced by the cable (51) displaces the second detent means located on the limbs (31) towards the first detent means of the base part (10).
Patent MX-PA04003441-A (MX)
Title: Video tripwire.
Inventor: SEVERSON WILLIAM E
IPC: G06T7/20
Filed: 2002-10-09
Abstract: A video tripwire system and method for implementing same comprises a sensing device (1) for producing video output, a communication medium (2) over which the video output is transmitted, an analysis system (5) for receiving the video output from the communications medium, and a user interface (6) for sending inputs to and receiving outputs from the analysis system, thereby enabling a user to create a virtual tripwire and to provide commands to the analysis system. The sensing device may be calibrated manually and/or automatically, to determine sensing device parameters for use by the system. The analysis system determines if the virtual tripwire has been crossed, by analyzing data from the sensing device, and triggers a response to a tripwire crossing.
Patent MX-PA04003974-A (MX)
Title: Linear basic compounds having nk-2 antagonist activity and formulations thereof.
Inventor: CARLO ALBERTO MAGGI
IPC: A61P29/00
Filed: 2002-10-28
Abstract: Described herein are compounds of formula (I) useful as antagonists of tachykinins in general, and in particular of neurokinin A; and the pharmaceutical formulations comprising the compounds of formula (I).
Patent MX-PA04010849-A (MX)
Title: Method and system for optimizing power resources in wireless devices.
Inventor: STEVEN JEFFREY GOLDBERG
IPC: H04W52/02
Filed: 2003-04-29
Abstract: A method and system is disclosed for a device to quickly determine if data is being sent to it. If no data is being sent to the device, the device may return to a sleep mode so as to conserve energy. The present invention includes organizing and transmitting, one at a time, all device destination identifiers. If a message listing search indicates that no message is being sent for a device, the device can continue with any other activity that needs servicing, or if no other activity is pending, it may shut down to conserve power until the next wake up period arrives. If the search returns a positive indication, the count value when the identifier is found can be used to determine the location of the pointer to the message.
Patent MX-PA04010861-A (MX)
Title: Injection device.
Inventor: MARTIN LAWRENCE HUGHES
IPC: A61M5/145
Filed: 2003-05-02
Abstract: An injection device for use with a syringe (30) having a bore (32) extending from an end surface (34), a needle (36) communicating with the bore through the end surface and a dispensing piston (38) movable in said bore towards said end surface so as to expel the content of the syringe through the needle, the injection device including a housing (60) having an opening (64) at one end through which the needle may extend, a resilient member for biassing the syringe and needle inwardly of the housing, a drive element (66) movable towards said one end so as to move the needle of the syringe out of the opening against the bias of the resilient member and to move the dispensing piston of the syringe towards the end surface, a delatch mechanism (72) operable to release the syringe such that the needle moves inwardly of the housing, a drive coupling (40) for extending from said drive element to the dispensing piston of the syringe so as to transfer movement of said drive element to the dispensing piston, wherein the drive coupling gradually reduces in length such that, after the drive element has moved the dispensing piston to the end surface, the drive element continues to move to said predetermined piston to the end surface, the drive element continuous to move to said predetermined position at which said delatch mechanism releases the syringe.
Patent MX-PA04012595-A (MX)
Title: Wrap for packaging at least one object, of the type consisting of a shrinkable plastic material sleeve.
Inventor: ERIC FRESNEL
IPC: B65D71/08
Filed: 2003-06-13
Abstract: The invention concerns a wrap for packaging object (s), consisting of a shrinkable plastic material sleeve (11) designed to be shrunk on the packaged object, said sleeve being obtained from a film folded on itself and closed by assembling the two end zones concerned. The invention is characterized in that said two end zones (12, 13) have substantially contiguous opposite free edges (12.1, 13.1), and they are mutually assembled by an overlapping strip (15) adhering to said zones on one surface (14) of the sleeve (11) on either side of the two opposite free zones, the other surface (16) of said sleeve being then substantially smooth. Thus, it is possible to produce an internally printed recyclable shrinkable sleeve with very satisfactory appearance for its inner or outer smooth surface.
Patent MX-PA05002621-A (MX)
Title: Diazabicyclic compounds useful in the treatment of cns and other disorders.
Inventor: O'DONELL CHRISTOPHER JOHN
IPC: A61P25/00
Filed: 2003-08-29
Abstract: The present invention relates to a compounds of formula (I): wherein A, B, D, E and F are defined herein; that are useful in treating central nervous system (CNS) diseases, disorders and conditions, such as but not limited to nicotine addiction, schizophrenia, depression, Alzheimer's disease, Parkinson's disease and ADHD. The present invention further comprises pharmaceutical compositions containing such compounds and methods of treatment comprising the use of such compounds.
Patent MX-PA05005355-A (MX)
Title: Anti-rotation device for mating connectors and methods of using the same.
Inventor: CHAD VAN LIERE
IPC: E21B17/043
Filed: 2005-05-19
Abstract: The present invention is generally directed to an anti-rotation device for mating connectors, and methods of using same. In one illustrative embodiment, the method comprises coupling a first connector to a second connector, removing at least a portion of the second connector after the first and second connectors are coupled together to thereby define a recess in the second connector, and coupling an anti-rotation member to at least one of the first and second connectors, wherein the anti-rotation member engages at least a portion of the first connector and is adapted to engage at least a portion of the recess in the second connector.
Patent MX-PA05005570-A (MX)
Title: Use of galanthamine and the derivatives thereof in the production of medicaments.
Inventor: PIRICH EBERHARD
IPC: A61P25/14
Filed: 2004-07-12
Abstract: The invention relates to the use of galanthamine and the cholinergically active derivatives thereof in the production of medicaments for preventive treatment of postoperative delirium and/or subsyndronal postoperative delirium.Galanthamine, the galathamine derivative(4aS, 6R, 8aS)- 6-hydroxy -3-methoxy -11-methyl -4a, 5, 9, 10- tetrahydro- 6H-benzofuro [3a, 3, 2-ef] [2] benzazepinium bromide and analogous salts, hydrates or solvates are advantageously suited for use according to the invention.
Patent MX-PA05007317-A (MX)
Title: The use of estrogen receptor alpha modulators for the treatment of multiphe sclerosis.
Inventor: STEVEN J ADELMAN
IPC: A61K31/56
Filed: 2004-01-05
Abstract: The present invention provides methods of treating an autoimmune pathology in a mammal, comprising administering an agent with estrogen receptor a agonist activity in particular a selective estrogen receptor modulator, to the mammal in an amount sufficient to decrease production of TH-1 and/or TH-2 cytokines. Also provided is a method of selecting compounds useful for the treatment of multiple sclerosis, comprising selecting a compound which has estrogen receptor a agonist activity.
Patent MX-PA05009348-A (MX)
Title: Sterilization of beclomethasone drug particles for pulmonary delivery.
Inventor: MARCO DELL UOMO
IPC: A61L2/04
Filed: 2004-03-02
Abstract: A process for the sterilization of water insoluble solid medicinal substances is described.The process provides the sterilization of beclomethasone, which is suitable for pulmonary administration. In particular, the process is used in industrial plants for the production of formulations of sterile beclomethasone for inhalation delivery, so as to avoid any modifications in particle size distribution and in the impurities profile of the drug. The process is carried out by heating a mixture of micronized beclomethasone and purified water only, preferably at a temperature of about 120degree C for 20 minutes. The process is particularly efficient and economic for the steam sterilization of beclomethasone dipropionate in formulations for pulmonary delivery.
Patent MX-PA05011225-A (MX)
Title: Combination therapies for chronic obstructive pulmonary disease (copd).
Inventor: RICHARDS IVAN MICHAEL
IPC: A61K31/445
Filed: 2004-04-05
Abstract: The invention features a method of treating asthma, COPD, allergic rhinitis, and infectious rhinitis by administering a first pharmaceutical agent including one or more compounds selected from the quarternary ammonium compounds of formulae I - V and a second pharmaceutical agent including one or more pharmaceutical agents selected from Adenosine A2a Receptor Agonists, D2-Dopamine Receptor Agonists, Phosphodiesterase Inhibitors (PDE's), corticosteroids, norepinephrine reuptake inhibitors, 4-hydroxy-7-[2-[2-[3- [2-phenylethoxy]- propylsulphonyllethylamino] ethyl] -1,3-benzothiazol-2(3H)-one, and pharmaceutically acceptable salts thereof, and non-quarternized antimuscarinic compounds.
Patent MX-PA05011693-A (MX)
Title: Method for extracting copper from leach solutions at elevated temperatures.
Inventor: VIRGIN MICHAEL J
IPC: C22B11/00
Filed: 2004-04-27
Abstract: Copper is extracted from aqueous copper leach solutions wherein the leach solutions have a temperature of at least 30 degree C. The method comprises contacting the aqueous solution with an extraction reagent of the formula (I) : wherein R is a linear or branched C10-18 alkyl group and R1 is H or CH3. These extraction reagents do not undergo any significant degradation normally encountered with the use of conventional reagents in leach solutions having temperatures equal to or greater than 30 degree C.
Patent MX-PA05012465-A (MX)
Title: N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors.
Inventor: VEDANANDA THALATHTHANI RALALAG
IPC: C07D403/12
Filed: 2004-05-19
Abstract: Compounds of the formula (I) provide pharmacological agents which bind to Peroxisome Proliferator-Activated Receptors (PPARs). Accordingly, the compounds of the instant invention are useful for the treatment of conditions mediated by the PPAR receptor activity in mammals. Such conditions include dyslipidemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, heart failure, myocardial infarction, vascular diseases, cardiovascular diseases, hypertension, obesity, inflammation, arthritis, cancer, AlzheimeraCOEs disease, skin disorders, respiratory diseases, ophthalmic disorders, inflammatory bowel diseases, ulcerative colitis, CrohnaCOEs disease, and conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X.
Patent MX-PA06000309-A (MX)
Title: WET SCRUBBING APPARATUS AND METHOD FOR CONTROLLING NOx EMISSIONS.
Inventor: MORIN ANDREW
IPC: B01D53/56
Filed: 2003-10-01
Abstract: An apparatus (1) for controlling NOx emissions which includes a chamber having a wall surface (114) and an interior (110), a flue gas entrance (100) and a flue gas exit (108) for a flue gas to enter and exit the interior of the chamber, a gas quenching zone (102) in which the temperature of the gas can be lowered, an ozone injection and retention zone (104) in the chamber, and a liquid spray zone (106) including at least one spray nozzle (200) for spraying a liquid towards the wall surface.
Patent MX-PA06000659-A (MX)
Title: Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin.
Inventor: OFT MARTIN
IPC: C12N5/09
Filed: 2004-07-16
Abstract: treatment for tumors by administering Hymic Stromal Lymphopoietin (TSLP). Diagnosis of neoplasms by contacting a sample with an anti-TSLP or anti-TSLP-receptor and detecting formation of an antibody-antigen complex.
Patent MX-PA06002761-A (MX)
Title: Crystalline form of bis [(e)-7 -[4-(4-fluorophenyl) -6-isopropyl -2-[methyl(methylsulfonyl) amino]pyrimidin -5-yl](3r, 5s)-3, 5-dihydroxyhept -6 -enoicacid] calcium salt.
Inventor: CRABB JEFFREY NORMAN
IPC: C07D239/42
Filed: 2004-09-08
Abstract: Two polymorphic forms of bis [(E)-7 -[4-(4-fluorophenyl) -6-isopropyl-2- [methyl(methylsulfonyl) amino]pyrimidin -5-yl](3R, 5S)-3, 5-dihydroxyhept-6 -enoic acid] calcium salt, processes for making them and their use as HMG Co-A reductase inhibitors are described.
Patent MX-PA06002874-A (MX)
Title: Gas phase oxidation catalyst with defined vanadium oxide particle size distribution.
Inventor: RUMMEL WOLFGANG
IPC: B01J23/00
Filed: 2004-09-24
Abstract: A method for production of a catalyst for gas phase oxidations is disclosed, whereby a suspension of Ti02 and V205 particles is applied to a fluidised inert support, wherein at least 90 vol. % of the V205 particles have a diameter of 20 mum or less and at least 95 vol. % of the V205 particles have a diameter of 30 mum or less. The defined particle size distribution of the V205 permits a high coating efficiency.
Patent MX-PA06005023-A (MX)
Title: Bicyclic pyrazolyl and imidazolyl compounds and uses thereof.
Inventor: DOW ROBERT LEE
IPC: C07D209/00
Filed: 2004-10-25
Abstract: Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.
Patent MX-PA06006194-A (MX)
Title: Low haze high strength polyethylene compositions.
Inventor: KWALK TAE HOON
IPC: C08L23/08
Filed: 2004-09-20
Abstract: A low density substantially linear polyethylene composition is described, including some that have: (a) a density of 0.935 g/cc or less; (b) a Haze of 10% or less, (c) a Dart Impact of 100 grams/mil or more, (d) an average overall long chain branching index of 0.95 or more; and (e) a slice long chain branching (SLCB) index of 0.85 or less for any portion of the composition having a molecular weight of 100,000 or above.
Patent MX-PA06012725-A (MX)
Title: Pixel shift display with minimal noise.
Inventor: WILLIS DONALD HENRY
IPC: G09G3/00
Filed: 2005-05-06
Abstract: A filter and method for reducing noise in a display in which successive frames comprising corresponding successive sets of frame pixels are displayed on a digital display device are provided. Pixels of successive frames are filtered so each pixel has an intensity value comprised of an integer part and a fractional part. At least one pixel of a first frame is grouped with at least one pixel of a second frame such that the pixel of the second frame lies spatially adjacent to the pixel of the first frame. The fractional parts of the first and second frame pixel intensity values are combined. The brightness of said grouped first and second frame pixels are controlled in accordance with their combined fractional parts.
Patent MX-PA06013265-A (MX)
Title: Flat-ended bag having an optimised splitting behaviour, and method for the production thereof.
Inventor: GUNTER WALTER
IPC: B65D75/00
Filed: 2005-05-13
Abstract: The invention relates to a flat-ended bag comprising a body and a bottom, especially a flat bottom, at least the body of said bag comprising at least one unidirectionally stretched film. The invention also relates to a method for producing one such flat-ended bag.
Patent MX-PA06014501-A (MX)
Title: Inhaler using pods.
Inventor: FRIBERG LARS
IPC: A61M16/00
Filed: 2005-06-09
Abstract: A medicament container for carrying a metered, finely divided, dry powder medication dose is disclosed. The medicament container, which is intended for administration by a dry powder inhaler device, constitutes a pod presents a bottom surface acting as a dose bed adapted for receiving a metered medication dose. The metered dose, carried by the pod, is protected from foreign matter, particularly moisture, after a sealing of the pod with a high barrier seal foil, which transforms the pod into a high barrier container. Furthermore the pod is formed such that the pod sealing foil can be slit open from a point of penetration at a first pod end to a point of exit at a second pod end by a cutter set in motion relative to the pod.
Patent MX-PA06014779-A (MX)
Title: Health jewelry utilizing silicone elastomer and process for producing the same.
Inventor: HIRATA YOSHIHIRO
IPC: A44C25/00
Filed: 2005-06-09
Abstract: A process for producing a body jewelry constituted of a silicone elastomer jewelry main-frame comprising, arranged on its skin contact side, a silicone elastomer layer having titanium micropowder mixed therein, the titanium micropowder at least composed mainly of titanium micropowder obtained by carrying out combustion of a mixed gas of oxygen and hydrogen in water under high pressure and melting elemental metallic titanium by means of resultant combustion gas to thereby deposit titanium micropowder in the water, and comprising, arranged outside, ornamental protrudent streaks of silicone elastomer. In particular, there is provided a body jewelry, available in ring form, constituted of a silicone elastomer jewelry main-frame comprising, arranged on its skin contact side, a silicone elastomer layer having titanium micropowder mixed therein, and comprising, arranged outside, ornamental protrudent streaks of silicone elastomer, which silicone elastomer jewelry main-frame is obtained by first providing a silicone elastomer jewelry main-frame with a continuous depressed portion, subsequently planting a titanium-micropowder-containing silicone elastomer layer in the continuous depressed portion, separately preparing ornamental protrudent streaks of silicone elastomer, and finally mounting the formerly obtained jewelry main-frame on the ornamental protrudent streaks, followed by thermal vulcanization to thereby effect integration. Further, there is provided a process for producing the body jewelry.
Patent MY-100212-A (MY)
Title: Improvements relating to the treatment of particulate materials
Inventor: ROLAND CLIFT
IPC: B01F33/40
Filed: 1986-11-26
Abstract: MOBILISATION APPARATUS FOR THE TREATMENT, DRYING FOR EXAMPLE, OF PARTICULATE MATERIAL COMPRISES A MOBILISATION ZONE BOUNDED BY UPWARDLY DIVERGENT WALLS. PARTICULATE MATERIAL IN THE ZONE IS MOBILISED BY BEING SUBJECTED TO A FLOW OF GASEOUS MOBILISING MEDIUM SUPPLIED AT A MULTIPLICITY OF SITES OF THE DIVERGENT WALLS. THE MATERIAL IS SIMULTANEOUSLY SUBJECTED TO A FLOW OF GASEOUS ACCELERATING MEDIUM SUPPLIED IN AN UPWARD DIRECTION FROM A LOWER REGION OF THE MOBILISATION ZONE. THERE OBTAINS IN THE MOBILISATION ZONE A CIRCULATORY PATTERN COMPRISING DOWNWARD FLOW AT THE DIVERGENT WALLS AND UPWARD FLOW FROM A LOWER REGION OF THE ZONE. IN ORDER TO DISCHARGE THE PARTICULATE MATERIAL FROM THE APPARATUS, MASK MEANS EXTENDING OUTWARDLY FROM THE LOWER END OF AN UPWARDLY EXTENDING DISCHARGE DUCT IS BROUGHT TO THE UPPER END OF THE MOBILISATION ZONE. THE RESULT IS THAT THE CIRCULATORY PATTERN IS DESTROYED AND THE MATERIAL IS PNEUMATICALLY TRANSPORTED UP THE DISCHARGE DUCT.(FIG 1)
Patent MY-101895-A (MY)
Title: 5-hetero-or aryl-substituted-imidazo [2,1-a] isoquinolines
Inventor: DR WILLIAM JOSEPH HOULIHAN
IPC: A61P43/00
Filed: 1987-07-11
Abstract: COMPOUNDS OF FORMULA 1(FORMULA I)WHEREIN R1 IS IN 8-OR 9-POSITION AND REPRESENTS HYDROGEN, CHLORO, FLUORO OR C1-3ALKYL AND R2 REPRESENTS THIENYL, FURYL OR(FORMULA I) WHEREIN EACH RO REPRESENTS INDEPENDENTLY HYDROGEN , FLUORO, CHLORO, C1-10ALKYL, C1-10ALKOXY OR C1-10ALKYLTHIO OR ONE RO IS HYDROGEN AND THE OTHER REPRESENTS TRI-(C1-3ALKYL) SILYL, TRIFLUOROMETHYL, PHENYL, MONOCHLOROPHENYL ,MONOFLUOROPHENYL, (FORMULA I) WHEREIN X, Y, R3 R3'' OR R4 ARE AS DEFINED HEREIN OR TWO RO''S ON ADJACENT CARBON ATOMS FORM METHYLENEDIOXY. THE COMPOUNDS ARE INDICATED FOR USE IN TREATING PAF-MEDIATED BRONCHOCONTRICTION AND EXTRAVASATION AND IN PART IN TREATING TUMORS.
Patent MY-101454-A (MY)
Title: Biological specimen collection device
Inventor: EDWARD L WILLIAMS
IPC: A61B10/00
Filed: 1987-09-29
Abstract: A BIOLOGICAL SPECIMEN COLLECTION DEVICE COMPRISES A SPECIMEN RECEPTACLE HAVING A CLOSED FIRST END AND AN OPEN SECOND END. A REMOVABLE CONDUIT IS PROVIDED FOR INTRODUCING A BIOLOGICAL SPECIMEN INTO THE RECEPTACLE AND IS CONNECTED TO THE SECOND END OF THE RECEPTACLE. A BASE REMOVABLY RECEIVES THE FIRST END OF THE RECEPTACLE AND SUPPORTS THE RECEPTACLE IN A SUBSTANTIALLY VERTICAL POSITION. A CAP IS REMOVABLY CONNECTED TO BE BASE, THIS CAP ADAPTED TO PROVIDE A LIQUID SEAL BETWEEN THE CAP AND THE OPEN SECOND END OF THE RECEPTACLE. THE CAP IS MAINTAINED IN A PROTECTIVE ENVIRONMENT DURING INTRODUCTION OF THE BIOLOGICAL SPECIMEN INTO THE RECEPTACLE. ACCESS IS PERMITTED TO THE CAP AFTER THE SPECIMEN HAS BEEN COLLECTED FOR SUBSEQUENTLY CAPPING THE OPEN END OF THE RECEPTACLE WITH ITS CONTENTS. (FIG.5)
Patent MY-101703-A (MY)
Title: Cosmetic
Inventor: TOSHIYUKI SUZUKI
IPC: A61Q5/00
Filed: 1987-12-26
Abstract: COSMETIC COMPRISING A DIGLYCERIDE WHICH IS LIQUID AT ROOM TEMPERATURE AND A POLYOLTYPE HUMECTANT. IT MAY TAKE ANY FORM SUCH AS AN OILY COSMETIC, EMULSION COSMETIC, AQUEOUS COSMETIC AND CAN SUITABLY BE APPLIED TO ROUGHENED SKIN, OR HAIR REDUIRING A HUMECTANT EFFECT. THEY CAN PROVIDE A HIGH, LONG- LASTING MOISTURIZING EFFECT, AND AT THE SAME TIME PRESERVE THE MOISTURIZING FUNCTION OF THE SKIN OR HAIR AFTER A LAPSE OF TIME OR EVEN AFTER THE PORTION TO WHICH IT WAS APPLIED HAS BEEN WASHED. THESE EFFECTS ARE FURTHER PROMOTED BY FORMULATING TO THE COSMETICS A SPECIFIC TYPE HYDROPHILIC HUMECTANT.
Patent MY-107271-A (MY)
Title: Intumescent fire-retardant and electrically-conductive coating material
Inventor: OTIS H HASTINGS
IPC: C09D5/24
Filed: 1990-10-22
Abstract: A FIRE-RETARDANT COATING MATERIAL INCLUDES A FLUID INTUMESCENT MATERIAL AND CONDUCTIVE PARTICLES OF VARIOUS SIZES DISPERSED OR SUSPENDED THEREIN FOR PARTICULAR APPLICATIONS. THE FLUID INTUMESCENT MATERIAL INCLUDES A FOAMING AGENT, A BLOWING AGENT GAS SOURCE, A CARBONIFIC OR CHARRING AGENT, A FILM-FORMING BINDER, A SOLVENT AND, IN SOME CASES, A PIGMENT OR FILLER. THE CONDUCTIVE PARTICLES ARE FORMED OF A SUBSTRATE AND A CONDUCTIVE COATING. (FIG. 2)
Patent MY-110169-A (MY)
Title: Highly absorbent and flexible cellulosic pulp fluff sheet
Inventor: ZULFIKAR MURJI
IPC: A61F13/15
Filed: 1992-01-03
Abstract: A HIGHLY ABSORBENT AND FLEXIBLE CALENDERED AND PERF-EMBOSSED CELLULOSIC PULP FLUFF SHEET FOR USE IN DISPOSABLE ABSORBENT PRODUCTS SUCH AS SANITARY NAPKINS, WOUND DRESSINGS, BANDAGES, INCONTINENCE PADS, DISPOSABLE DIAPERS AND THE LIKE. THE INVENTION ALSO EXTENDS TO A METHOD FOR MANUFACTURING THE HIGHLY ABSORBENT AND FLEXIBLE PULP FLUFF SHEET AND ITS METHOD OF USE IN DISPOSABLE ABSORBENT PRODUCTS.(FIG 5)